SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001437749-22-018824
Filing Date
2022-08-04
Accepted
2022-08-04 13:03:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B4 navb20220802_424b4.htm 424B4 1033209
2 navb20220211_s1img001.jpg GRAPHIC 2924
  Complete submission text file 0001437749-22-018824.txt   1038474
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-262691 | Film No.: 221135726
SIC: 2835 In Vitro & In Vivo Diagnostic Substances